Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2026. 06. 10.
 ÀÌÁ¾Àå±â ÆÇ¸·-ÆÇ¸·µµ°ü ¿¬±¸ workshop
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2010.01.18. 09:37:40   Á¶È¸: 4820

2010³â 1¿ù 15ÀÏ ¿ÀÈÄ 5½Ã~ 8 ½Ã, 1¿ù 16ÀÏ ¿ÀÀü 9½Ã~11 ½Ã»çÀÌ¿¡ 2010³âµµ ½ÉÀåÆÇ¸·¿¬±¸ workshopÀ»  ÀÎõ½Ã ¿ËÁø±º ¿µÈï¸é ¼±À縮 14-1 ( ¿À¼Çºô ÆÒ¼Ç ) ¿¡¼­ °³ÃÖÇÏ¿´´Ù.

¹ßÇ¥³»¿ëÀº; 1¿ù15ÀÏ

17;00  ±è¿ëÁø : Overview for cardiovascular xenograft.

17;25  ¹Ú¼º½Ä : Xenoreactive antigen removal (¥á-Gal) with ¥á-galactosidase

17;40  Á¶Àº¾Ö : Biomechanical change by fixation : crosslingking characteristics

17;55  ÃÖ¼±¿µ : Immunological Evaluation for xenograft : Development of recombinant ¥á-

galactosidase and xenoreactive antigen removal with ¥á-galactosidase

18;10  ÀÌ  ö : The effect of anticalcification using ¥á-Gal knock out mouse model 1

18;25  ÀÓÈ«±¹ : The effect of anticalcification using ¥á-Gal knock out mouse model 2

18;40  ¹Úõ¼ö : Evaluation of change in anti ¥á-Gal and anti non-Gal antibody in human

serum for bioprosthetic heart valve implantation

18;55  ±è¼öȯ : Geometry & design of heart valves : aortic & pulmonic valves

19;10  ¿À»ï¼¼ : The design of bioprosthetic heart valve, porcine & pericardial valve

19;25  ÀÌâÇÏ : The design of valved conduit

19;40  È«°­¼± : Manufacture & evaluation of implantable valve with stent materials and percutaneous implantable stented valve

 1¿ù16ÀÏ¿¡´Â  

9;00 Àå¿ì¼º  ; Studies of mechanical test ; effects of tensile strength and elasticity

9;15 ÃÖâÈÞ  : Studies on valve fixation pressure : transvalvular & distension pressure

9;30 ¾çÁöÇõ  : Large animal experiment for xenograft implantation (pulmonary valved conduit with heparin detoxification & decellularized pericardial conduit).

9;45 ÀÌ¿µ¿Á  : Effect of anticalcification treatment with tissue preservation and fixation : in vivo study using small animal subcutaneous implantation

10;00 ÀåÇü¿ì : Effect of anticalcification treatment with various tissue preservation and fixation : in vivo study using small animal subcutaneous implantation

10;15 Á¶¼º±Ô : Effect of anticalcification treatment with various tissue preservation and fixation : in vivo study using small animal subcutaneous implantation

10;30 À¯Àç¼® : Study on Genipin : An alternative natural crosslinking agent for heterograft

¿Í°°ÀÌ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´À¸¸ç ¸¹Àº ÅäÀǰ¡ ÀÖ¾ú´Ù.

±Ý¹ø ÀÌ workshopÀº ¸ðµç Âü¼®ÀÚ¿¡°Ô À¯ÀÍÇÏ°í ¼ºÈ²¸® ÁøÇàµÇ¾ú´Ù.

LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2026. 06. 10.  Àüü±Û: 227  ¹æ¹®¼ö: 1197892
227 2026³â ´ëÇÑ ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú Á¦ 40Â÷ Ãá°èÇмú´ëȸ °ü¸®ÀÚ2026.06.08.6
226 TW Transcatheter valve symposium °ü¸®ÀÚ2026.06.08.8
225 2025 APCIS & 3 day Seminar on CHD °ü¸®ÀÚ 2025.11.17.247
224 2025³â Á¦57Â÷ ´ëÇÑ ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú Ãß°èÇмú´ëȸ °ü¸®ÀÚ 2025.11.03.223
223 28th Update Symposium of Ped. CS & Cardiology °ü¸®ÀÚ 2025.08.26.371
222 The 2025 China-Korea-Japan Pediatric Heart Forum °ü¸®ÀÚ 2025.06.09.472
221 HVS 2025 Annual Meeting °ü¸®ÀÚ 2025.04.22.561
220 Á¦25Â÷ ´ëÇѼҾƽÉÀåÇÐȸ Ãá°èÇмú´ëȸ °ü¸®ÀÚ 2025.03.31.527
219 ½ÉÀåÇ÷°ü¿Ü°úÇÐ(°³Á¤ÆÇ) ÃâÆÇ±â³ä½Ä °ü¸®ÀÚ 2025.01.03.663
218 32Â÷ ATCSA annual meeting °ü¸®ÀÚ2024.11.26.800
RELOAD WRITE
1 [2] [3] [4] [5] [6] [7] [8] [9] [10]  ¢º 23